Market capitalisation, EUR | 231,745.90 m |
EPS, EUR | 1.92 |
P/B ratio | 6.48 |
P/E ratio | 39.70 |
Dividend yield | 1.72% |
Revenue, EUR | 42,374.41 m |
Net income, EUR | 5,508.28 m |
Profit margin | 13.00% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
Invesco NASDAQ-100 Equal Weight UCITS ETF Acc | 0.99% | Equity Technology Equal Weighted | 102 | 0.20% | 122 | +12.72% | A3EE27 | IE000L2SA8K5 |
First Trust Value Line® Dividend Index UCITS ETF Acc | 0.49% | Equity United States Dividend | 203 | 0.70% | 14 | +9.33% | A2PZMV | IE00BKVKW020 |
WisdomTree Megatrends UCITS ETF USD | 0.05% | Equity World Social/Environmental Innovation | 642 | 0.50% | 46 | - | A3EYCN | IE0000902GT6 |
Invesco EQQQ Nasdaq-100 UCITS ETF Acc | 0.30% | Equity United States Technology | 102 | 0.30% | 2,029 | +26.73% | A2N6RV | IE00BFZXGZ54 |
Invesco Nasdaq-100 ESG UCITS ETF Acc | 0.28% | Equity United States Technology Social/Environmental | 94 | 0.25% | 1,038 | +28.97% | A3CZGT | IE000COQKPO9 |
WisdomTree BioRevolution UCITS ETF USD Acc | 1.24% | Equity World Health Care Social/Environmental Biotech | 89 | 0.45% | 3 | -3.65% | A3CY21 | IE000O8KMPM1 |
iShares Nasdaq 100 UCITS ETF EUR Hedged Acc | 0.31% | Equity United States Technology | 102 | 0.36% | 648 | +23.93% | A2N34W | IE00BYVQ9F29 |
iShares Nasdaq 100 UCITS ETF (DE) | 0.30% | Equity United States Technology | 102 | 0.31% | 3,827 | +26.52% | A0F5UF | DE000A0F5UF5 |
L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0.72% | Equity World Social/Environmental Innovation | 359 | 0.60% | 4 | +1.94% | A3DHPA | IE000VTOHNZ0 |
Xtrackers Nasdaq 100 UCITS ETF 1C | 0.30% | Equity United States Technology | 102 | 0.20% | 694 | +26.86% | A2QJU3 | IE00BMFKG444 |
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 3.87% | Equity United States Health Care Biotech | 215 | 0.35% | 35 | +15.27% | A2JDYM | IE00BDZVHG35 |
iShares Nasdaq US Biotechnology UCITS ETF | 3.87% | Equity United States Health Care Biotech | 215 | 0.35% | 476 | +15.03% | A2DWAW | IE00BYXG2H39 |
Invesco Nasdaq-100 UCITS ETF EUR Hedged | 0.30% | Equity United States Technology | 102 | 0.35% | 228 | +24.11% | A2DT9V | IE00BYVTMS52 |
Invesco Nasdaq-100 UCITS ETF CHF Hedged | 0.30% | Equity United States Technology | 102 | 0.35% | 296 | +21.14% | A2JAN0 | IE00BYVTMT69 |
Invesco Nasdaq-100 UCITS ETF GBP Hedged | 0.30% | Equity United States Technology | 102 | 0.35% | 271 | +26.64% | A2JNFA | IE00BYVTMW98 |
Deka Nasdaq-100® UCITS ETF | 0.30% | Equity United States Technology | 102 | 0.25% | 38 | - | ETFL62 | DE000ETFL623 |
L&G Pharma Breakthrough UCITS ETF | 2.93% | Equity World Health Care Innovation | 42 | 0.49% | 16 | -3.76% | A2H9XR | IE00BF0H7608 |
iShares Nasdaq 100 UCITS ETF (Acc) | 0.31% | Equity United States Technology | 102 | 0.33% | 12,877 | +26.68% | A0YEDL | IE00B53SZB19 |
Invesco EQQQ Nasdaq-100 UCITS ETF | 0.30% | Equity United States Technology | 102 | 0.30% | 6,577 | +26.96% | 801498 | IE0032077012 |
YTD | +21.64% |
1 month | +6.01% |
3 months | +4.93% |
6 months | +32.90% |
1 year | +17.07% |
3 years | +53.40% |
5 years | - |
Since inception (MAX) | +74.43% |
2023 | -5.34% |
2022 | +30.34% |
2021 | - |
2020 | - |
Volatility 1 year | 19.79% |
Volatility 3 years | 23.40% |
Volatility 5 years | - |
Return per risk 1 year | 0.86 |
Return per risk 3 years | 0.65 |
Return per risk 5 years | - |
Maximum drawdown 1 year | -14.33% |
Maximum drawdown 3 years | -20.92% |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -20.92% |